BRUSSELS REPS PHARMA
The computed 12-month bankruptcy probability of BRUSSELS REPS PHARMA is 1.0% (low). The company has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 23 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 19-12-2025 | 2025-00587952 |
| 31-12-2023 | volledig | 04-11-2024 | 2024-00530035 |
| 31-12-2022 | volledig | 28-07-2023 | 2023-00302392 |
| 31-12-2021 | volledig | 05-10-2022 | 2022-20456558 |
| 31-12-2020 | volledig | 03-12-2021 | 2021-79200596 |
| 31-12-2019 | volledig | 13-01-2021 | 2021-00900509 |
| 31-12-2018 | volledig | 15-07-2019 | 2019-34500448 |
| 31-12-2017 | volledig | 19-11-2018 | 2018-72600587 |
| 31-12-2016 | volledig | 23-08-2017 | 2017-48200084 |
| 31-12-2015 | volledig | 14-12-2016 | 2016-70100357 |
| NACE primary | Wholesale trade(46150) |
| Legal form | Private limited company(610) |
| Incorporation | 24-04-2003 |
| Status | Active |
| Postal code | 1070 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21524C0064/00G006 | Brussels | 280 m² | 1 · 352 m² | 13.8 m · 2 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-12-2022 Urszula KWIATKOWSKA appointed as director
- Urszula KWIATKOWSKA — Bestuurder
Technical details
{
"events": [
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Urszula KWIATKOWSKA",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Bernard Houet",
"firm_city": null,
"firm_name": null,
"office_city": "Wavre",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-28",
"filing_date": "2022-12-23",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2022-12-19",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0480.073.487",
"name_full": "SMB PHARMA",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | BRUSSELS REPS PHARMA |
| AbbreviationFR | B.R.Pharma |